50.46
+0.57
+(1.14%)
At close: April 17 at 6:52:10 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 234.29M | 243.72M | 978.81M | 1.02B |
| Low Estimate | 232.3M | 242.3M | 973.6M | 1.01B |
| High Estimate | 237.24M | 244.87M | 980.36M | 1.03B |
| Year Ago Sales | 223.28M | 233.81M | 939.83M | 978.81M |
| Sales Growth (year/est) | 4.93% | 4.24% | 4.15% | 4.23% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0HC2.L | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 4/17/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/14/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 11/8/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 11/8/2024 |
| Initiated | Jefferies: Buy | 11/5/2024 |
| Maintains | Roth MKM: Buy to Buy | 10/9/2024 |